文献速递泌尿生殖技术与安全MR

钆基对比剂在大鼠体内的生物分布与形态分析

Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats.
PubMed 文献 · Radiology · 2023-01-01

这项前瞻性动物研究于2021年11月至2022年9月进行,32只健康大鼠连续10天接受钆特酸、钆特醇、钆布醇或钆贝酸(2.0 mmol/kg),用MRI、质谱、元素成像和电子顺磁共振波谱比较四种钆基对比剂的药代动力学、分布与形态。结果显示肾皮质钆潴留最高(350-1720 nmol/g),钆特醇潴留最低;肾皮质R2*与离体钆浓度相关(r=0.95;P<.001),T1加权信号强度与离体钆浓度无关联(r=0.38;P=.10);注射后52天所有对比剂在肾皮质主要保持完整形态。

要点

  • 肾皮质钆潴留高于其他受检标本(均值范围350-1720 nmol/g vs 0.40-401 nmol/g),钆特醇潴留最低。
  • 肾皮质R2*与离体钆浓度相关(r=0.95;P<.001),T1加权信号强度与离体钆浓度无关联(r=0.38;P=.10)。
  • 注射后52天肾皮质电子顺磁共振波谱显示所有钆基对比剂主要保持完整形态。

核心结论

  • 与其他大环类钆基对比剂相比,钆特醇给药后钆潴留水平最低;肾脏皮质潴留钆浓度最高,但T1加权MRI对检测该组织残留钆不敏感。

研究设计与样本

  • 前瞻性动物研究,32只健康大鼠连续10天接受钆特酸、钆特醇、钆布醇或钆贝酸(2.0 mmol/kg),以未接触钆基对比剂大鼠为对照;于注射后3、17、34、52天采集肾脏三维T1加权超短回波时间图像和R2*图,于注射后17天和52天用质谱测量23种器官、组织和体液标本的钆浓度,用元素成像评估肾脏钆分布,用电子顺磁共振波谱评估肾皮质钆形态。

关键影像表现/征象

  • 注射后17天所有钆基对比剂的肾皮质钆潴留高于其他所有受检标本(均值范围350-1720 nmol/g vs 0.40-401 nmol/g;P值范围.001-.70)。
  • 注射后52天肾皮质电子顺磁共振波谱显示所有钆基对比剂主要保持完整形态。

诊断标准与关键数值

  • 肾皮质R2*值与离体测得的钆浓度相关(r=0.95;P<.001)。
  • T1加权信号强度与离体钆浓度无关联(r=0.38;P=.10)。

临床应用与阅片要点

  • 肾皮质是钆潴留最高的部位,但T1加权MRI对检测该组织残留钆不敏感。
  • 肾皮质R2*与离体钆浓度相关(r=0.95;P<.001),而T1加权信号强度与离体钆浓度无关联(r=0.38;P=.10)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Gadolinium retention has been observed in organs of patients with normal renal function; however, the biodistribution and speciation of residual gadolinium is not well understood. Purpose To compare the pharmacokinetics, distribution, and speciation of four gadolinium-based contrast agents (GBCAs) in healthy rats using MRI, mass spectrometry, elemental imaging, and electron paramagnetic resonance (EPR) spectroscopy. Materials and Methods In this prospective animal study performed between November 2021 and September 2022, 32 rats received a dose of gadoterate, gadoteridol, gadobutrol, or gadobenate (2.0 mmol/kg) for 10 consecutive days. GBCA-naive rats were used as controls. Three-dimensional T1-weighted ultrashort echo time images and R2* maps of the kidneys were acquired at 3, 17, 34, and 52 days after injection. At 17 and 52 days after injection, gadolinium concentrations in 23 organ, tissue, and fluid specimens were measured with mass spectrometry; gadolinium distribution in the kidneys was evaluated using elemental imaging; and gadolinium speciation in the kidney cortex was assessed using EPR spectroscopy. Data were assessed with analysis of variance, Kruskal-Wallis test, analysis of response profiles, and Pearson correlation analysis. Results For all GBCAs, the kidney cortex exhibited higher gadolinium retention at 17 days after injection than all other specimens tested (mean range, 350-1720 nmol/g vs 0.40-401 nmol/g; P value range, .001-.70), with gadoteridol showing the lowest level of retention. Renal cortex R2* values correlated with gadolinium concentrations measured ex vivo (r = 0.95; P < .001), whereas no associations were found between T1-weighted signal intensity and ex vivo gadolinium concentration (r = 0.38; P = .10). EPR spectroscopy analysis of rat kidney cortex samples showed that all GBCAs were primarily intact at 52 days after injection. Conclusion Compared with other macrocyclic GBCAs, gadoteridol administration led to the lowest level of retention. The highest concentration of gadolinium was retained in the kidney cortex, but T1-weighted MRI was not sensitive for detecting residual gadolinium in this tissue. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Tweedle in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Le Fur M, Moon BF, Zhou IY, et al. Gadolinium-based Contrast Agent Biodistribution and Speciation in Rats. Radiology. 2023. PMID: 37874235. doi:10.1148/radiol.230984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。